Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SPER Market Research Pvt. Ltd. | PRODUCT CODE: 1634598

Cover Image

PUBLISHER: SPER Market Research Pvt. Ltd. | PRODUCT CODE: 1634598

Intraosseous Infusion Devices Market Growth, Size, Trends Analysis- By Product, By Route of Administration, By Technology, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2033

PUBLISHED:
PAGES: 260 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 4250
PDF (Group License)
USD 5650
PDF (Company License)
USD 7450

Add to Cart

Intraosseous Infusion Devices Market Introduction and Overview

According to SPER Market Research, 'Global Intraosseous Infusion Devices Market Size- - By Product, By Route of Administration, By Technology, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2033' states that the Global Intraosseous Infusion Devices Market is estimated to reach USD 8.74 billion by 2033 with a CAGR of 7.11%.

To provide an entrance site into the systemic circulation, any drugs or solutions are infused intraosseously into the human bone marrow. This method is typically used in situations where intravenous access is either impossible or unavailable. Additionally, this method is used for medicine delivery and vascular access in both adults and children. The sternum (FAST1), humerus EZ-IO, and proximal and distal tibia are often where the infusion is introduced.

The global market for intraosseous infusion (IO) devices was significantly impacted by the COVID-19 pandemic's changes to supply and demand. On the one hand, the pandemic's increased demand for timely and efficient medical care-particularly in emergency and critical care settings where patient circumstances or a lack of accessible veins made traditional intravenous access more challenging-led to a rise in the use of IO devices.

Scope of the Report:

Report Metric Details

Market size available for years 2020-2033

Base year considered 2023

Forecast period 2024-2033

Segments covered By Product, By Route of Administration, By Technology, By End User.

Regions covered

North America, Asia-Pacific, Latin America, Middle East & Africa and Europe.

Companies Covered

Aero Healthcare, Becton Dickinson and Company, Biopsybell, Cardinal Health, Inc., Cook Medical Incorporated, PAVmed, PerSys Medical, Pyng Medical Corp., SAM Medical, Teleflex, Inc., Others.

Intraosseous Infusion Devices Market Segmentation:

By Product: Based on the Product, Global Intraosseous Infusion Devices Market is segmented as; B.I.G, FAST1, EZ-IO, FASTR, IO Needles, Others.

By Route of Administration: Based on the Route of Administration, Global Intraosseous Infusion Devices Market is as: Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus, Head of Humerus.

By Technology: Based on the Route of Technology, Global Intraosseous Infusion Devices Market is as: Manual, Automatic, Impact Driven, Power Dril.

By End User: Based on the Route of End User, Global Intraosseous Infusion Devices Market is as: EMS, Hospitals, Ambulatory Surgical Centers, Cardiac Care Centers.

By Region: This research also include data for North America, Europe, Asia-Pacific Middle East & Africa and South America.

Product Code: MEDE2462

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1. Research data source
    • 2.1.1. Secondary Data
    • 2.1.2. Primary Data
    • 2.1.3. SPERs internal database
    • 2.1.4. Premium insight from KOLs
  • 2.2. Market size estimation
    • 2.2.1. Top-down and Bottom-up approach
  • 2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1. Drivers
    • 4.1.2. Restraints
    • 4.1.3. Opportunities
    • 4.1.4. Challenges
  • 4.2. COVID-19 Impacts of the Global Intraosseous Infusion Devices Market

5. Market variable and outlook

  • 5.1. SWOT Analysis
    • 5.1.1. Strengths
    • 5.1.2. Weaknesses
    • 5.1.3. Opportunities
    • 5.1.4. Threats
  • 5.2. PESTEL Analysis
    • 5.2.1. Political Landscape
    • 5.2.2. Economic Landscape
    • 5.2.3. Social Landscape
    • 5.2.4. Technological Landscape
    • 5.2.5. Environmental Landscape
    • 5.2.6. Legal Landscape
  • 5.3. PORTERs Five Forces
    • 5.3.1. Bargaining power of suppliers
    • 5.3.2. Bargaining power of buyers
    • 5.3.3. Threat of Substitute
    • 5.3.4. Threat of new entrant
    • 5.3.5. Competitive rivalry
  • 5.4. Heat Map Analysis

6. Competitive Landscape

  • 6.1. Global Intraosseous Infusion Devices Market Manufacturing Base Distribution, Sales Area, Product Type
  • 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Intraosseous Infusion Devices Market

7. Global Intraosseous Infusion Devices Market, By Product (USD Million) 2020-2033

  • 7.1. Global Intraosseous Infusion Devices Market Size, Share and Forecast, By Type, 2020-2026
  • 7.2. Global Intraosseous Infusion Devices Market Size, Share and Forecast, By Type, 2027-2033
  • 7.3. B.I.G
  • 7.4. FAST1
  • 7.5. EZ-IO
  • 7.6. FASTR
  • 7.7. IO Needles
  • 7.8. Others

8. Global Intraosseous Infusion Devices Market, By Route of Administration (USD Million) 2020-2033

  • 8.1. Global Intraosseous Infusion Devices Market Size, Share and Forecast, By Route of Administration, 2020-2026
  • 8.2. Global Intraosseous Infusion Devices Market Size, Share and Forecast, By Route of Administration, 2027-2033
  • 8.3. Sternum
  • 8.4. Distal & Proximal Tibia
  • 8.5. Distal Femur
  • 8.6. Calcaneus
  • 8.7. Head of Humerus

9. Global Intraosseous Infusion Devices Market, By Technology (USD Million) 2020-2033

  • 9.1. Global Intraosseous Infusion Devices Market Size, Share and Forecast, By Technology, 2020-2026
  • 9.2. Global Intraosseous Infusion Devices Market Size, Share and Forecast, By Technology, 2027-2033
  • 9.1. Manual
  • 9.2. Automatic
  • 9.3. Impact Driven
  • 9.4. Power Drill

10. Global Intraosseous Infusion Devices Market, By End User (USD Million) 2020-2033

  • 10.1. Global Intraosseous Infusion Devices Market Size, Share and Forecast, By End User, 2020-2026
  • 10.2. Global Intraosseous Infusion Devices Market Size, Share and Forecast, By End User, 2027-2033
  • 10.3. EMS
  • 10.4. Hospitals
  • 10.5. Ambulatory Surgical Centers
  • 10.6. Cardiac Care Centers

11. Global Intraosseous Infusion Devices Market Forecast, 2020-2033 (USD Million)

  • 11.1. Global Intraosseous Infusion Devices Market Size and Market Share

12. Global Intraosseous Infusion Devices Market, By Region, 2020-2033 (USD Million)

  • 12.1. Global Intraosseous Infusion Devices Market Size and Market Share By Region (2020-2026)
  • 12.2. Global Intraosseous Infusion Devices Market Size and Market Share By Region (2027-2033)
  • 12.3. Asia-Pacific
    • 12.3.1. Australia
    • 12.3.2. China
    • 12.3.3. India
    • 12.3.4. Japan
    • 12.3.5. South Korea
    • 12.3.6. Rest of Asia-Pacific
  • 12.4. Europe
    • 12.4.1. France
    • 12.4.2. Germany
    • 12.4.3. Italy
    • 12.4.4. Spain
    • 12.4.5. United Kingdom
    • 12.4.6. Rest of Europe
  • 12.5. Middle East and Africa
    • 12.5.1. Kingdom of Saudi Arabia
    • 12.5.2. United Arab Emirates
    • 12.5.3. Qatar
    • 12.5.4. South Africa
    • 12.5.5. Egypt
    • 12.5.6. Morocco
    • 12.5.7. Nigeria
    • 12.5.8. Rest of Middle-East and Africa
  • 12.6. North America
    • 12.6.1. Canada
    • 12.6.2. Mexico
    • 12.6.3. United States
  • 12.7. Latin America
    • 12.7.1. Argentina
    • 12.7.2. Brazil
    • 12.7.3. Rest of Latin America

13. Company Profile

  • 13.1. Aero Healthcare
    • 13.1.1. Company details
    • 13.1.2. Financial outlook
    • 13.1.3. Product summary
    • 13.1.4. Recent developments
  • 13.2. Becton Dickinson and Company
    • 13.2.1. Company details
    • 13.2.2. Financial outlook
    • 13.2.3. Product summary
    • 13.2.4. Recent developments
  • 13.3. Biopsybell
    • 13.3.1. Company details
    • 13.3.2. Financial outlook
    • 13.3.3. Product summary
    • 13.3.4. Recent developments
  • 13.4. Cardinal Health, Inc.
    • 13.4.1. Company details
    • 13.4.2. Financial outlook
    • 13.4.3. Product summary
    • 13.4.4. Recent developments
  • 13.5. Cook Medical Incorporated
    • 13.5.1. Company details
    • 13.5.2. Financial outlook
    • 13.5.3. Product summary
    • 13.5.4. Recent developments
  • 13.6. PAVmed
    • 13.6.1. Company details
    • 13.6.2. Financial outlook
    • 13.6.3. Product summary
    • 13.6.4. Recent developments
  • 13.7. PerSys Medical
    • 13.7.1. Company details
    • 13.7.2. Financial outlook
    • 13.7.3. Product summary
    • 13.7.4. Recent developments
  • 13.8. Pyng Medical Corp.
    • 13.8.1. Company details
    • 13.8.2. Financial outlook
    • 13.8.3. Product summary
    • 13.8.4. Recent developments
  • 13.9. SAM Medical
    • 13.9.1. Company details
    • 13.9.2. Financial outlook
    • 13.9.3. Product summary
    • 13.9.4. Recent developments
  • 13.10. Teleflex, Inc.
    • 13.10.1. Company details
    • 13.10.2. Financial outlook
    • 13.10.3. Product summary
    • 13.10.4. Recent developments
  • 13.11. Others

14. Conclusion

15. List of Abbreviations

16. Reference Links

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!